Jonathan Bernard Rosenberg Senior Research Associate in Genetic Medicine

Senior Research Associate in Genetic Medicine, Genetic Medicine , Weill Cornell Medical College 2016 -
Research Associate in Genetic Medicine, Genetic Medicine , Weill Cornell Medical College 2007 - 2016

Publications

Sort by

Co-Author Network

selected publications

Anti-Phospho-Tau Gene Therapy for Chronic Traumatic Encephalopathy. Human gene therapy. 2019 Academic Article GET IT
Times cited: 4
In Vivo Potency Assay for Adeno-Associated Virus-Based Gene Therapy Vectors Using AAVrh.10 as an Example. Human gene therapy methods. 2018 Academic Article GET IT
Times cited: 8
Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2. Experimental neurology. 2018 Academic Article GET IT
Times cited: 10
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. Human gene therapy. Clinical development. 2018 Academic Article GET IT
Times cited: 121
Gene therapy for metachromatic leukodystrophy. Journal of neuroscience research. 2016 Review GET IT
Times cited: 73
Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques. Pharmacology, biochemistry, and behavior. 2016 Academic Article GET IT
Times cited: 24
Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates. Human gene therapy. Clinical development. 2014 Academic Article GET IT
Times cited: 54
Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine. Human gene therapy. Clinical development. 2014 Academic Article GET IT
Times cited: 29
Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency. Human gene therapy. Clinical development. 2013 Academic Article GET IT
Times cited: 39
Gene therapy to stimulate angiogenesis to treat diffuse coronary artery disease. Human gene therapy. 2013 Review GET IT
Times cited: 19
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine. Human gene therapy. 2013 Academic Article GET IT
Times cited: 16
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2013 Academic Article GET IT
Times cited: 41
Safety of direct cardiac administration of AdVEGF-All6A+, a replication-deficient adenovirus vector cDNA/genomic hybrid expressing all three major isoforms of human vascular endothelial growth factor, to the ischemic myocardium of rats. Human gene therapy. Clinical development. 2013 Academic Article GET IT
Times cited: 9
Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity. Human gene therapy. 2012 Academic Article GET IT
Times cited: 22
AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation. Science translational medicine. 2012 Academic Article GET IT
Times cited: 48
In vivo gene transfer strategies to achieve partial correction of von Willebrand disease. Human gene therapy. 2012 Academic Article GET IT
Times cited: 18
AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior. Human gene therapy. 2012 Academic Article GET IT
Times cited: 39
Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2011 Academic Article GET IT
Times cited: 75
Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs. Molecular therapy : the journal of the American Society of Gene Therapy. 2011 Academic Article GET IT
Times cited: 57

Research

Sort by

Co-investigator Network

Funding awarded

Lexeo Biopharma Agreement awarded by LEXEO Therapeutics, Inc. Co-Investigator 2025 - 2027

Background

education and training

Ph.D., University of Wisconsin, Milwaukee 94
B.S., Arizona State University 1984

Contact

full name

Jonathan Bernard Rosenberg

primary email

jor2024@med.cornell.edu